With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
Scientists may have discovered a way to naturally regulate blood sugar levels and sugar cravings that works similarly to ...
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Researchers have discovered gut bacteria that may naturally suppress hunger, offering a potential alternative to drugs like ...
Coya Therapeutics, Inc. (NASDAQ:COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for ...